Year archive

Laekna, Inc. — 2026 filings

All 17 regulatory filings released by Laekna, Inc. (2105) in 2026, sourced directly from the official regulator.

17 Filings

2026 Period

2026 filings (17)

Filing	Released	Lang
PROXY FORM FOR THE ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2026-05-14	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2026-05-14	English
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES, RESELL TREASURY SHARES AND REPURCHASE SHARES; PROPOSED RE-ELECTION OF DIRECTORS; PROPOSED RE-APPOINTMENT OF AUDITOR; PROPOSED GRANT OF RSUs TO DI Proxy Solicitation & Information Statement	2026-05-14	English
Next Day Disclosure Return Share Issue/Capital Change	2026-05-11	English
GRANT OF RESTRICTED SHARE UNITS Regulatory Filings	2026-05-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 Regulatory Filings	2026-05-06	English
INSIDE INFORMATION POSITIVE TOPLINE RESULTS PHASE III CLINICAL TRIAL (AFFIRM-205) OF LAE002 (AFURESERTIB) MET PRIMARY ENDPOINT OF PFS DEMONSTRATED HIGHLY STATISTICALLY SIGNIFICANT AND CLINICALLY MEANI Regulatory Filings	2026-04-15	English
2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT Environmental & Social Information	2026-04-13	English
2025 ANNUAL REPORT Regulatory Filings	2026-04-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 Regulatory Filings	2026-04-02	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 Annual Report FY 2025	2026-03-18	English
VOLUNTARY ANNOUNCEMENT POSITIVE TOPLINE RESULTS FROM U.S. PHASE I SAD STUDY OF LAE102 SHOWED ENCOURAGING TRENDS TOWARD LEAN MASS INCREASE AND FAT MASS REDUCTION Regulatory Filings	2026-03-10	English
DATE OF BOARD MEETING Report Publication Announcement	2026-03-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026 Regulatory Filings	2026-03-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 Share Issue/Capital Change	2026-02-05	English
VOLUNTARY ANNOUNCEMENT THE U.S. FOOD AND DRUG ADMINISTRATION ACCEPTANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR LAE118 Regulatory Filings	2026-01-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 Share Issue/Capital Change	2026-01-05	English